Neogen reported $100M in Cash and Equivalent for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cash And Equivalent Change
Agilent A:US USD 1.05B 18M
Atrion ATRI:US USD 16.44M 15.83M
Avanos Medical Inc AVNS:US USD 117M 10.5M
Bio Rad Laboratories BIO:US USD 517.94M 78.64M
Cerus CERS:US USD 28.88M 3.43M
Danaher DHR:US USD 6B 845M
Integra Lifesciences IART:US USD 511.94M 64.78M
Meridian Bioscience VIVO:US USD 1.03M 6K
Nanostring Technologies NSTG:US USD 117.07M 8.96M
Neogen NEOG:US USD 100M 7.1M
Orasure Technologies OSUR:US USD 75.2M 9.05M
Pacific Biosciences Of California PACB:US USD 304.43M 6.01M
Quidel QDEL:US USD 212.2M 166.8M
Rockwell Medical RMTI:US USD 12.98M 17.8M
Sientra SIEN:US USD 18.97M 6.02M
Staar Surgical STAA:US USD 129.24M 73.25M
Thermo Fisher Scientific TMO:US USD 8.52B 5.6B
Utah Medical Products UTMD:US USD 69.51M 3.29M
Zoetis ZTS:US USD 2.5B 145M